{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:44:18Z","timestamp":1791870258792,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and aims<\/jats:title>\n            <jats:p>The role of biomarkers in diagnosing pulmonary hypertension (PH) and distinguishing between pre- and post-capillary PH remains poorly understood. We aimed to identify biomarkers with a strong association with mean pulmonary arterial pressure, mPAP (PH diagnosis) and pulmonary vascular resistance, PVR (pre-capillary component), but not with pulmonary arterial wedge pressure, PAWP (post-capillary component).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Blood samples were collected in patients undergoing right heart catheterization within a prospective cross-sectional study. Biomarkers measured included BMP10, NT-proBNP, ANG2, ESM1\/endocan, FGF23, GDF15, IGFBP7, IL6, MyBPC3, proC3, and proC6\/endotrophin. Primary outcomes were mPAP, PVR, and PAWP, while secondary outcomes included PH diagnosis (mPAP\u2009&gt;\u200920\u00a0mmHg) and elevated PVR (&gt;\u20092 Wood units). Multivariable linear and logistic regression models were used to assess the relationship between biomarkers and outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 127 patients included (age 66\u2009\u00b1\u200913\u00a0years, 54% female), 73% were diagnosed with PH. BMP10, NT-proBNP, ANG2, MyBPC3, and FGF23 showed a strong association with mPAP (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). BMP10 and NT-proBNP were strongly associated with PVR (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), while NT-proBNP and ANG2 were strongly associated with PAWP (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). NT-proBNP had the strongest association with the diagnosis of PH (area under the curve\u2009=\u20090.76). BMP10 was the only biomarker associated with elevated PVR (OR 1.60, 95%CI 1.01\u20132.54, <jats:italic>p<\/jats:italic>\u2009=\u20090.04) but not with PAWP (<jats:italic>p<\/jats:italic>\u2009=\u20090.86).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Several biomarkers were strongly associated with mPAP, PAWP, and PVR. BMP10 was the only biomarker strongly associated with mPAP and PVR, but not with PAWP, thus reflecting the pre-capillary PH component. Measurement of BMP10 along with NT-proBNP may aid in diagnosing PH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s00392-024-02546-8","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T11:22:39Z","timestamp":1726744959000},"page":"239-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["BMP10 reflects pre-capillary pulmonary hemodynamics: association of biomarkers and hemodynamic parameters in pulmonary hypertension"],"prefix":"10.1007","volume":"114","author":[{"given":"Elisa","family":"Hennings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Aeschbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Coslovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Paladini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian","family":"Voellmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurin","family":"Lampart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Conen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Zuern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"K\u00fchne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Osswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-5494","authenticated-orcid":false,"given":"Otmar","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"2546_CR1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, R\u00e5degran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S (2022) 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43:3618\u20133731","journal-title":"Eur Heart J"},{"key":"2546_CR2","doi-asserted-by":"crossref","unstructured":"Lewis RA, Durrington C, Condliffe R, Kiely DG (2020) BNP\/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing? Eur Respir Rev 29(156)","DOI":"10.1183\/16000617.0009-2020"},{"key":"2546_CR3","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41598-022-05769-9","volume":"12","author":"PB Meyre","year":"2022","unstructured":"Meyre PB, Aeschbacher S, Blum S, Voellmin G, Kastner PM, Hennings E, Kaufmann BA, K\u00fchne M, Osswald S, Conen D (2022) Biomarkers associated with rhythm status after cardioversion in patients with atrial fibrillation. Sci Rep 12:1680","journal-title":"Sci Rep"},{"key":"2546_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00392-019-01513-y","volume":"109","author":"BT Santema","year":"2020","unstructured":"Santema BT, Chan MMY, Tromp J, Dokter M, van der Wal HH, Emmens JE, Takens J, Samani NJ, Ng LL, Lang CC, van der Meer P, Ter MJM, Damman K, Dickstein K, Cleland JG, Zannad F, Anker SD, Metra M, van der Harst P, de Boer RA, van Veldhuisen DJ, Rienstra M, Lam CSP, Voors AA (2020) The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clin Res Cardiol 109:331\u2013338","journal-title":"Clin Res Cardiol"},{"key":"2546_CR5","first-page":"w14202","volume":"145","author":"LC Huber","year":"2015","unstructured":"Huber LC, Bye H, Brock M (2015) The pathogenesis of pulmonary hypertension\u2014an update. Swiss Med Wkly 145:w14202","journal-title":"Swiss Med Wkly"},{"key":"2546_CR6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.119.045401","volume":"142","author":"NR Tucker","year":"2020","unstructured":"Tucker NR, Chaffin M, Fleming SJ, Hall AW, Parsons VA, Bedi KCJ, Akkad A-D, Herndon CN, Arduini A, Papangeli I, Roselli C, Aguet F, Choi SH, Ardlie KG, Babadi M, Margulies KB, Stegmann CM, Ellinor PT (2020) Transcriptional and cellular diversity of the human heart. Circulation 142:466\u2013482","journal-title":"Circulation"},{"key":"2546_CR7","doi-asserted-by":"publisher","first-page":"e139179","DOI":"10.1172\/jci.insight.139179","volume":"5","author":"JS Reyat","year":"2020","unstructured":"Reyat JS, Chua W, Cardoso VR, Witten A, Kastner PM, Kabir SN, Sinner MF, Wesselink R, Holmes AP, Pavlovic D, Stoll M, K\u00e4\u00e4b S, Gkoutos GV, de Groot JR, Kirchhof P, Fabritz L (2020) Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation. JCI Insight 5:e139179","journal-title":"JCI Insight"},{"key":"2546_CR8","doi-asserted-by":"publisher","first-page":"e26389","DOI":"10.1371\/journal.pone.0026389","volume":"6","author":"PC Kahr","year":"2011","unstructured":"Kahr PC, Piccini I, Fabritz L, Greber B, Sch\u00f6ler H, Scheld HH, Hoffmeier A, Brown NA, Kirchhof P (2011) Systematic analysis of gene expression differences between left and right atria in different mouse strains and in human atrial tissue. PLoS ONE 6:e26389","journal-title":"PLoS ONE"},{"key":"2546_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1161\/CIRCRESAHA.107.163188","volume":"102","author":"A Tessari","year":"2008","unstructured":"Tessari A, Pietrobon M, Notte A, Cifelli G, Gage PJ, Schneider MD, Lembo G, Campione M (2008) Myocardial Pitx2 differentially regulates the left atrial identity and ventricular asymmetric remodeling programs. Circ Res 102:813\u2013822","journal-title":"Circ Res"},{"key":"2546_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/dvdy.395","volume":"251","author":"A Desroches-Castan","year":"2022","unstructured":"Desroches-Castan A, Tillet E, Bouvard C, Bailly S (2022) BMP9 and BMP10: Two close vascular quiescence partners that stand out. Dev Dyn 251:178\u2013197","journal-title":"Dev Dyn"},{"key":"2546_CR11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00078-2019","author":"NW Morrell","year":"2019","unstructured":"Morrell NW (2019) Finding the needle in the haystack: BMP9 and 10 emerge from the genome in pulmonary arterial hypertension. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00078-2019","journal-title":"Eur Respir J"},{"key":"2546_CR12","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1182\/blood-2006-07-034124","volume":"109","author":"L David","year":"2007","unstructured":"David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109:1953\u20131961","journal-title":"Blood"},{"key":"2546_CR13","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1074\/jbc.M115.683292","volume":"291","author":"H Jiang","year":"2016","unstructured":"Jiang H, Salmon RM, Upton PD, Wei Z, Lawera A, Davenport AP, Morrell NW, Li W (2016) The prodomain-bound form of bone morphogenetic protein 10 is biologically active on endothelial cells. J Biol Chem 291:2954\u20132966","journal-title":"J Biol Chem"},{"key":"2546_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30111-2","author":"J Guo","year":"2022","unstructured":"Guo J, Liu B, Thorikay M, Yu M, Li X, Tong Z, Salmon RM, Read RJ, ten Dijke P, Morrell NW, Li W (2022) Crystal structures of BMPRII extracellular domain in binary and ternary receptor complexes with BMP10. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-022-30111-2","journal-title":"Nat Commun"},{"key":"2546_CR15","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1161\/CIRCULATIONAHA.120.047375","volume":"143","author":"L Wang","year":"2021","unstructured":"Wang L, Rice M, Swist S, Kubin T, Wu F, Wang S, Kraut S, Weissmann N, B\u00f6ttger T, Wheeler M, Schneider A, Braun T (2021) BMP9 and BMP10 Act Directly on Vascular Smooth Muscle Cells for Generation and Maintenance of the Contractile State. Circulation 143:1394\u20131410","journal-title":"Circulation"},{"key":"2546_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/79226","volume":"26","author":"KB Lane","year":"2000","unstructured":"Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA, Loyd JE, Nichols WC, Trembath RC, Aldred M, Brannon CA, Conneally PM, Foroud T, Fretwell N, Gaddipati R, Koller D, Loyd EJ, Morgan N, Newman JH, Prince MA, G\u00fcell CV, Wheeler L (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 26:81\u201384","journal-title":"Nat Genet"},{"key":"2546_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/CIRCRESAHA.122.321554","volume":"132","author":"I Cuthbertson","year":"2023","unstructured":"Cuthbertson I, Morrell NW, Caruso P (2023) BMPR2 Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension. Circ Res 132:109\u2013126","journal-title":"Circ Res"},{"key":"2546_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1053-2498(00)00352-1","volume":"20","author":"RC Trembath","year":"2001","unstructured":"Trembath RC (2001) Mutations in the TGF-beta type 1 receptor, ALK1, in combined primary pulmonary hypertension and hereditary haemorrhagic telangiectasia, implies pathway specificity. J Heart Lung Transpl 20:175","journal-title":"J Heart Lung Transpl"},{"key":"2546_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/jmg.40.12.865","volume":"40","author":"RE Harrison","year":"2003","unstructured":"Harrison RE, Flanagan JA, Sankelo M, Abdalla SA, Rowell J, Machado RD, Elliott CG, Robbins IM, Olschewski H, McLaughlin V, Gruenig E, Kermeen F, Laitinen T, Morrell NW, Halme M, R\u00e4is\u00e4nen-Sakolowski TRC (2003) Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet 40:865\u2013871","journal-title":"J Med Genet"},{"key":"2546_CR20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1164\/rccm.201906-1141OC","volume":"201","author":"J Hodgson","year":"2020","unstructured":"Hodgson J, Swietlik EM, Salmon RM, Hadinnapola C, Nikolic I, Wharton J, Guo J, Liley J, Haimel M, Bleda M, Southgate L, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani H-A, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, Lawrie A, MacKenzie Ross RV, Moledina S, Montani D, Olschewski A, Olschewski H, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Suntharalingam J, Toshner MR, Trembath RC, Vonk Noordegraaf A, Wort SJ, Wilkins MR, Yu PB, Li W, Gr\u00e4f S, Upton PD, Morrell NW (2020) Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 201:575\u2013585","journal-title":"Am J Respir Crit Care Med"},{"key":"2546_CR21","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-2600(20)30317-9","volume":"8","author":"BA Maron","year":"2020","unstructured":"Maron BA, Brittain EL, Hess E, Waldo SW, Bar\u00f3n AE, Huang S, Goldstein RH, Assad T, Wertheim BM, Alba GA, Leopold JA, Olschewski H, Gali\u00e8 N, Simonneau G, Kovacs G, Tedford RJ, Humbert M, Choudhary G (2020) Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. Lancet Respir Med 8:873\u2013884","journal-title":"Lancet Respir Med"},{"key":"2546_CR22","doi-asserted-by":"publisher","first-page":"e028255","DOI":"10.1161\/JAHA.122.028255","volume":"12","author":"E Hennings","year":"2023","unstructured":"Hennings E, Blum S, Aeschbacher S, Coslovsky M, Knecht S, Eken C, Lischer M, Paladini RE, Krisai P, Reichlin T, Rodondi N, Beer JH, Ammann P, Conte G, De PML, Kobza R, Blum MR, Bossard M, Kastner P, Ziegler A, M\u00fcller C, Bonati LH, Pfister O, Zuern CS, Conen D, K\u00fchne M, Osswald S (2023) Bone Morphogenetic protein 10-a novel biomarker to predict adverse outcomes in patients with atrial fibrillation. J Am Heart Assoc 12:e028255","journal-title":"J Am Heart Assoc"},{"key":"2546_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.healun.2022.08.021","volume":"42","author":"CM Hadinnapola","year":"2023","unstructured":"Hadinnapola CM, Southwood M, Hern\u00e1ndez-S\u00e1nchez J, Bunclark K, Newnham M, Swietlik EM, Cannon J, Preston SD, Sheares K, Taboada D, Screaton N, Jenkins DP, Morrell NW, Toshner M, Pepke-Zaba J (2023) Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH-Results from a prospective discovery and validation biomarker study. J Heart Lung Transpl 42:398\u2013405","journal-title":"J Heart Lung Transpl"},{"key":"2546_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-023-02162-y","author":"L Widmann","year":"2023","unstructured":"Widmann L, Keranov S, Jafari L, Liebetrau C, Keller T, Troidl C, Kriechbaum S, Voss S, Arsalan M, Richter MJ, Tello K, Gall H, Ghofrani HA, Guth S, Seeger W, Hamm CW, D\u00f6rr O, Nef H (2023) Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-023-02162-y","journal-title":"Clin Res Cardiol"},{"key":"2546_CR25","first-page":"e202007","volume":"2020","author":"M Wilkins","year":"2020","unstructured":"Wilkins M (2020) Pulmonary hypertension: proteins in the blood. Glob Cardiol Sci Pract 2020:e202007","journal-title":"Glob Cardiol Sci Pract"},{"key":"2546_CR26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04196-2020","author":"L Hobohm","year":"2021","unstructured":"Hobohm L, K\u00f6lmel S, Niemann C, K\u00fcmpers P, Krieg VJ, Bochenek ML, Lukasz AH, Reiss Y, Plate K-H, Liebetrau C, Wiedenroth CB, Guth S, M\u00fcnzel T, Hasenfu\u00df G, Wenzel P, Mayer E, Konstantinides SV, Sch\u00e4fer K, Lankeit M (2021) Role of angiopoietin-2 in venous thrombus resolution and chronic thromboembolic disease. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.04196-2020","journal-title":"Eur Respir J"},{"key":"2546_CR27","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1093\/eurheartj\/ehq226","volume":"31","author":"P K\u00fcmpers","year":"2010","unstructured":"K\u00fcmpers P, Nickel N, Lukasz A, Golpon H, Westerkamp V, Olsson KM, Jonigk D, Maegel L, Bockmeyer CL, David S, Hoeper MM (2010) Circulating angiopoietins in idiopathic pulmonary arterial hypertension. Eur Heart J 31:2291\u20132300","journal-title":"Eur Heart J"},{"key":"2546_CR28","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1530\/JME-20-0178","volume":"66","author":"BB Ho","year":"2021","unstructured":"Ho BB, Bergwitz C (2021) FGF23 signalling and physiology. J Mol Endocrinol 66:R23\u2013R32","journal-title":"J Mol Endocrinol"},{"key":"2546_CR29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ijcard.2016.03.005","volume":"212","author":"E Eleuteri","year":"2016","unstructured":"Eleuteri E, Di SA, Giordano A, Corr\u00e0 U, Tarro Genta F, Gnemmi I, Giannuzzi P (2016) Prognostic value of angiopoietin-2 in patients with chronic heart failure. Int J Cardiol 212:364\u2013368","journal-title":"Int J Cardiol"},{"key":"2546_CR30","doi-asserted-by":"publisher","first-page":"e000936","DOI":"10.1161\/JAHA.114.000936","volume":"3","author":"PL Lutsey","year":"2014","unstructured":"Lutsey PL, Alonso A, Selvin E, Pankow JS, Michos ED, Agarwal SK, Loehr LR, Eckfeldt JH, Coresh J (2014) Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study. J Am Heart Assoc 3:e000936","journal-title":"J Am Heart Assoc"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-024-02546-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-024-02546-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-024-02546-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:10:39Z","timestamp":1739977839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-024-02546-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2546"],"URL":"https:\/\/doi.org\/10.1007\/s00392-024-02546-8","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S. Aeschbacher received speaker fee from Roche Diagnostics outside of the submitted work. D. Conen received consultancy fees from Roche Diagnostics and Trimedics, as well as speaker fees from Servier. M. K\u00fchne reports grants from the Swiss National Science Foundation (Grant numbers 33CS30_148474, 33CS30_177520, 32473B_176178, 32003B_197524), the Swiss Heart Foundation, the Foundation for Cardiovascular Research Basel and the University of Basel, grants from Bayer, grants from Pfizer, grants from Boston Scientific, grants from BMS, grants from Biotronik, grants and personal fees from Daiichi Sankyo. C. M\u00fcller received research support from the Swiss National Science Foundation, Swiss Heart Foundation, KTI, University Hospital Basel, University of Basel, Abbott, Astra Zeneca, Beckman Coulter, Brahms, Idorsia, Novartis, LSI Medience Corporation, Ortho Clinical Diagnostics, Quidel, Roche, Siemens, Singulex, SpinChip, and Sphingotec, all outside the current work and paid to the institution, as well as speaker honoraria\/consulting honoraria from Abbott, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, BMS, Idorsia, Novartis, Osler, Roche, Sanofi, SpinChip, and Singulex, all outside the current work and paid to the institution. S. Osswald received research grants from the Swiss National Science Foundation and Swiss Heart Foundation, Foundation for CardioVascular Research Basel, and F. Hoffmann-La Roche Ltd., and educational and speaker grants from F. Hoffmann-La Roche Ltd., Bayer, Novartis, Sanofi, AstraZeneca, Daiichi-Sankyo, and Pfizer. O. Pfister received speaker\/consulting honoraria or travel support from Astra Zeneca, Bayer, Boehringer-Ingelheim, Daiichi Sankyo, Novartis, Pfizer, Sanofi, and Vifor Pharma. C.S. Zuern received travel support from Cardiomatics, Poland. The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}